Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coagulation Disorder Neonatal”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03333486
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Leukemia in RemissionAcute Lymphoblastic Leukemia+34 more
Roswell Park Cancer Institute 31
Not applicableStudy completedNCT00212459
What this trial is testing

The Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs

Who this might be right for
Hemophilia AHemophilia B
New York Presbyterian Hospital 14
Large-scale testing (Phase 3)Study completedNCT02954575
What this trial is testing

Clinical Study to Investigate the PK, Efficacy, and Safety of Wilate in Patients With Severe Hemophilia A

Who this might be right for
Severe Hemophilia A
Octapharma 57
Post-approval studies (Phase 4)UnknownNCT02479087
What this trial is testing

Safety/Efficacy Study to Assess Whether FVIII/VWF Concentrate Can Induce Immune Tolerance in Haemophilia A Patients

Who this might be right for
Hemophilia A
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 20
Not applicableStudy completedNCT05752565
What this trial is testing

Physical Activity and FVIII Elimination: Relevance to Personalized Therapy in Severe Hemophilia A

Who this might be right for
Hemophilia A
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Early research (Phase 1)Study completedNCT01238367
What this trial is testing

A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With Haemophilia A: An Extension to Trial NN7008-3543

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 6
Not applicableNot Yet RecruitingNCT05891899
What this trial is testing

Belgian Antithrombin Deficiency Registry

Who this might be right for
Antithrombin III Deficiency
Universitair Ziekenhuis Brussel 1,000
Not applicableStudy completedNCT06357572
What this trial is testing

Real-life Clinical FEIBA Samples Measured Using the Version A of the HemA EnzySystem

Who this might be right for
Hemophilia A With InhibitorHemophilia A
Enzyre B.V. 6
Post-approval studies (Phase 4)Study completedNCT00284193
What this trial is testing

Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII

Who this might be right for
Hemophilia A
Sheba Medical Center 5
Large-scale testing (Phase 3)Study completedNCT02795767
What this trial is testing

Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors

Who this might be right for
Hemophilia A
Hoffmann-La Roche 88
Early research (Phase 1)Study completedNCT00716716
What this trial is testing

Phase I/IIa Study of FIXFc in Hemophilia B Patients

Who this might be right for
Hemophilia B
Bioverativ Therapeutics Inc. 10
Large-scale testing (Phase 3)WithdrawnNCT02048111
What this trial is testing

Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B

Who this might be right for
Hemophilia B
Cangene Corporation
Testing effectiveness (Phase 2)Ended earlyNCT04899232
What this trial is testing

Antithrombin III in Infectious Disease Caused by COVID-19

Who this might be right for
Antithrombin III DeficiencyCovid19
Enrique Ginzburg 52
Large-scale testing (Phase 3)Study completedNCT04845399
What this trial is testing

Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A

Who this might be right for
Hemophilia A
Zhengzhou Gensciences Inc 101
Not applicableUnknownNCT03914209
What this trial is testing

Extended Half-Life (EHL) Clotting Factor for Improving the Musculoskeletal Health of Patients With Hemophilia

Who this might be right for
Haemophilia
Investigación en Hemofilia y Fisioterapia 40
Post-approval studies (Phase 4)Looking for participantsNCT06145373
What this trial is testing

Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab

Who this might be right for
Hemophilia A
Sanofi 20
Not applicableStudy completedNCT03430154
What this trial is testing

Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)

Who this might be right for
Haemophilia A, Haemophilia B, Obesity
Novo Nordisk A/S 317
Not applicableStudy completedNCT02869074
What this trial is testing

Molecular and Clinical Profile of Von Willebrand Disease in Spain

Who this might be right for
Von Willebrand Disease
Spanish Society of Thrombosis and Haemostasis 790
Post-approval studies (Phase 4)WithdrawnNCT00168051
What this trial is testing

Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer
Large-scale testing (Phase 3)WithdrawnNCT00916656
What this trial is testing

Fibrinogen Concentrate (Human) - Efficacy and Safety Study

Who this might be right for
AfibrinogenemiaHypofibrinogenemiaFibrinogen Deficiency
CSL Behring
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation